BMS-P5 free base
BMS-P5 free base is an orally bioavailable, specific PAD4 inhibitor. It suppresses neutrophil extracellular trap formation and has been shown in vivo to delay symptom onset and disease progression in multiple myeloma mouse models, highlighting its potential as a research tool for oncology and immunology.
Product Specifications
CAS Number
1550371-22-6
Product Name Alternative
Inhibit, myeloma, Multiple, NET, Inhibitor, BMS P5 free base, BMS-P5, BMSP5 free base, BMS-P5 free base, BMS-P-5 free base, Peptidylarginine Deiminase, peptidylarginine deiminase 4 (PAD4), Protein Arginine Deiminase
Field of Research
Epigenetics & Chromatin
Purity
99.88% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.12 mM) ; DMSO:10 mg/mL (21.16 mM)
Smiles
COc1cc (cc2nc (-c3cc4cccnc4n3CC3CC3) n (C) c12) C (=O) N1C[C@H] (N) CC[C@@H]1C
Molecular Formula
C27H32N6O2
Molecular Weight
472.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9182-Dylight594 100 µg
Anti-Furin Antibody Picoband® (Dylight594 Conjugate)
Sign In for Pricing
View Details 
040428-AP 200 µL
PRG2, ID (LPPR3, PHP2, PRG2, Lipid phosphate phosphatase-related protein type 3, PAP-2-like protein 2, Plasticity-related gene 2 protein) (AP) discontinued
Sign In for Pricing
View Details TMAY-02869-01 20 µL
Anti-SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody (9Z26)
Sign In for Pricing
View Details TMAY-02869-02 100 µL
Anti-SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody (9Z26)
Sign In for Pricing
View Details